| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.09. | XFRA NEW INSTRUMENTS AVAILABLE ON 23.09.2026 | 418 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.09.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.09.2026
Aktien
1 US4618651073 Iochpe-Maxion S.A. ADR
2... ► Artikel lesen | |
| 01.09. | H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment | 2 | Investing.com | ||
| 31.08. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| 12.08. | H.C. Wainwright raises Alpha Tau Medical stock price target to $16 | 1 | Investing.com | ||
| 12.08. | H.C. Wainwright hebt Kursziel für Alpha Tau Medical auf 16 $ an | 3 | Investing.com Deutsch | ||
| 10.08. | Alpha Tau Medical GAAP EPS of -$0.25 | 1 | Seeking Alpha | ||
| 10.08. | Alpha Tau Medical Ltd.: Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update | 378 | GlobeNewswire (Europe) | - Groundbreaking interim results from the U.S. recurrent glioblastoma REGAIN trial demonstrated 100% local disease control and a 67% complete response rate, followed by FDA clearance to complete trial... ► Artikel lesen | |
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| 10.08. | Alpha Tau plans dual listing on Nasdaq and TASE to expand access for Israeli investors | 4 | Seeking Alpha | ||
| 10.08. | Alpha Tau Medical Ltd.: Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) | 1 | GlobeNewswire (USA) | ||
| 10.08. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | H.C. Wainwright reiterates Alpha Tau Medical stock rating at buy | 1 | Investing.com | ||
| 21.07. | Alpha Tau rises on Alpha DaRT head and neck cancer data | 5 | Seeking Alpha | ||
| 21.07. | Alpha Tau reports positive trial results for cancer therapy combo | 4 | Investing.com | ||
| 21.07. | Alpha Tau meldet positive Studienergebnisse für kombinierte Krebstherapie | 1 | Investing.com Deutsch | ||
| 21.07. | Alpha Tau Medical Ltd.: Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, ... | 355 | GlobeNewswire (Europe) | - Podium presentation at the American Head and Neck Society (AHNS) 12th International Conference on Head and Neck Cancer to report results from a study of Alpha DaRT in combination with pembrolizumab... ► Artikel lesen | |
| 17.07. | H.C. Wainwright reiterates Alpha Tau Medical stock rating on immunocompromised patient treatment | 1 | Investing.com | ||
| 17.07. | H.C. Wainwright bestätigt Rating für Alpha Tau Medical nach Behandlungserfolg bei immunsupprimierten Patienten | 2 | Investing.com Deutsch | ||
| 15.07. | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center | 322 | GlobeNewswire (Europe) | - The ADMIRE study, by treating immunocompromised patients, builds on the momentum of Alpha Tau's ReSTART pivotal trial for recurrent cSCC, which recently completed patient enrollment, under which... ► Artikel lesen | |
| 15.07. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 23.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NYXOAH | 1,160 | 0,00 % | Nyxoah Appoints Liam Kelly as Chief Executive Officer | REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Appoints Liam Kelly as Chief Executive Officer Further strengthening the Company's strategic U.S. presence and focus Mont-Saint-Guibert, Belgium - September... ► Artikel lesen | |
| INSILICO MEDICINE | 4,760 | -4,42 % | INSILICO Nominates VAV1 Molecular Glue Degrader ISM9546 as Preclinical Candidate | ||
| TACTILE SYSTEMS TECHNOLOGY | 19,790 | -0,75 % | Tactile Systems Technology, Inc.: Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve Wearable Compression Device for VA and DoD Patients | MINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,300 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BILLIONTOONE | 94,44 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,970 | 0,00 % | EQS-Adhoc: Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen Giza | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Personalentscheidungen / Vorstand
Fresenius Medical Care AG: Wechsel im Vorstandsvorsitz - Shervin J. Korangy folgt auf Helen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,67 | +0,03 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 43,275 | +1,11 % | VW und Autobauer im Fokus: DAX vor dem nächsten Schub? Diese Woche wird für Anleger entscheidend | © Foto: Boris Roessler/dpaDer DAX dürfte freundlich in die neue Woche starten. Auch die europäischen Futures liegen im Plus. Doch Öl, Inflation und die beginnende US-Berichtssaison könnten schnell für... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,650 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| HEARTFLOW | 50,32 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| PROGYNY | 27,395 | 0,00 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| GENEDX | 64,89 | -0,11 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| SIEMENS HEALTHINEERS | 40,210 | +0,73 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,325 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| PROCEPT BIOROBOTICS | 19,110 | +0,05 % | PROCEPT BioRobotics to Report Third Quarter 2026 Financial Results on November 4th, 2026 |